What are Pseudo Tablets?

The kratom market has changed quickly.

For years, most people knew kratom as a plant powder, capsule, or tea. It was usually sold as a botanical product made from dried leaves of Mitragyna speciosa. Today, the market looks very different. You can now find concentrated kratom products like shots, 7OH tablets, MIT extracts, enhanced chewables, and products marketed as Pseudo tablets.

That raises an important question:

What are Pseudo tablets, and are they the same as regular kratom?

The short answer is no.

Pseudo tablets are usually associated with mitragynine pseudoindoxyl, a potent kratom-related compound connected to mitragynine and 7-hydroxymitragynine. These tablets are not the same as traditional kratom leaf powder. They belong to a newer category of concentrated alkaloid products that may feel much stronger, act differently in the body, and carry more safety and legal uncertainty.

This guide explains what Pseudo tablets are, how they work, why they are controversial, and what consumers should know before treating them like ordinary kratom.

First, What Does “Pseudo” Mean?

In this context, “Pseudo” usually refers to mitragynine pseudoindoxyl.

Mitragynine pseudoindoxyl is a kratom-related compound. It can be described as a rearrangement product connected to 7-hydroxymitragynine, also called 7OH. Scientific summaries also note that it can be produced in blood as a metabolite of 7-hydroxymitragynine.

This is important because Pseudo is not just another name for regular kratom.

Traditional kratom contains a wide range of naturally occurring alkaloids. Mitragynine is usually the main one. 7OH appears naturally in much smaller amounts. Pseudo is different because it is connected to metabolic or chemical transformation of those alkaloids.

That places it in a more complex category.

When consumers see a product marketed as “Pseudo tablets,” they are usually not looking at basic kratom powder in tablet form. They are looking at a concentrated product built around a much more potent kratom-related compound.

What are Pseudo Tablets?

Pseudo tablets are concentrated alkaloid tablets that usually contain, or claim to contain, mitragynine pseudoindoxyl.

They are typically sold in small tablet, chewable, or dissolvable formats. The format makes them look simple and controlled. But the active compound may be much more powerful than traditional kratom leaf.

That is the key difference.

Regular kratom products are usually made from dried plant material. You may see powders, capsules, or teas. These products contain many alkaloids together, including mitragynine and smaller amounts of other compounds.

Pseudo tablets focus on a specific potent compound. That means the experience may feel much more targeted and intense.

This is why Pseudo tablets are often discussed alongside other high-potency kratom products, such as 7OH tablets, MIT extracts, and enhanced alkaloid blends.

How Pseudo Tablets Differ From Regular Kratom?

The easiest way to understand the difference is to compare whole plant use with concentrated alkaloid use.

Traditional kratom is closer to drinking coffee. You consume the plant material, and the effects come from a mix of active compounds working together.

Pseudo tablets are closer to taking a concentrated caffeine tablet. The source may still be plant-related, but the final product is far more concentrated and less like the original plant.

That changes the entire user experience.

Regular kratom often has a slower onset and a broader feel. Pseudo tablets may feel stronger, heavier, and more opioid-like. They also may build tolerance faster because the active compound is more potent.

This is one reason some long-time kratom users are concerned. They worry that products like Pseudo tablets are moving the market away from traditional botanical use and closer to designer opioid-style products.

How Pseudo Relates to MIT and 7OH?

To understand Pseudo tablets properly, you need to know the basic kratom alkaloid family.

Mitragynine, often called MIT, is the most abundant active alkaloid in kratom. It is the main compound people associate with traditional kratom effects. In Thai kratom varieties, mitragynine has been reported as the dominant alkaloid, while 7OH is usually present only in small amounts.

7-hydroxymitragynine, or 7OH, is much more potent than mitragynine. It occurs naturally in kratom in small amounts, but modern products often concentrate it or produce it through processing. The FDA has raised concern about concentrated 7OH products, and in 2025 it recommended DEA control of 7OH.

Mitragynine pseudoindoxyl, or Pseudo, is connected to 7OH and is described as a mu-opioid receptor agonist and delta-opioid receptor antagonist. Research summaries describe it as having strong opioid receptor affinity compared with mitragynine and 7OH.

In simpler terms:

• MIT is the classic kratom alkaloid.
• 7OH is stronger and more opioid-like.
• Pseudo may be even more potent and pharmacologically complex.

That is why Pseudo tablets deserve more caution than ordinary kratom powder.

Why are Pseudo Tablets Becoming Popular?

The main reason is potency.

Many kratom consumers start with powder or capsules. Over time, some develop tolerance. The same amount no longer feels as noticeable. That pushes some users toward extracts, shots, and stronger alkaloid products.

Pseudo tablets fit into that demand.

They are compact, discreet, and often marketed as fast-acting. They also appeal to people who do not want to consume large amounts of bitter kratom powder.

For experienced users, a tablet format may feel cleaner and more convenient.

But convenience can create a false sense of safety. A small tablet does not always mean a mild product. With Pseudo tablets, the strength may be much higher than the size suggests.

That is one of the biggest risks.

What Do Pseudo Tablets Feel Like?

User reports vary a lot.

Some people describe Pseudo tablets as deeply relaxing and euphoric. Others describe strong body warmth, sedation, and relief from discomfort. Many compare the effect to high-potency 7OH products rather than regular kratom.

The experience may feel less like a mild botanical supplement and more like a concentrated opioid-like product.

That does not mean every person will react the same way. Body chemistry matters. Tolerance matters. Product quality matters. The amount of active compound in the tablet matters too.

Still, most reports point in the same direction:

Pseudo tablets are usually stronger than traditional kratom.

They may also be less functional for daytime use, especially for people without tolerance. Strong sedation, dizziness, nausea, and impaired coordination may occur.

This is why they should not be treated casually.

Are Pseudo Tablets Stronger Than 7OH?

This is one of the most common questions.

The answer is not simple, because commercial products vary. Some products may be accurately labeled. Others may not be. There is no universal manufacturing standard across the market.

From a pharmacology perspective, mitragynine pseudoindoxyl has been described as having very strong affinity at mu-opioid receptors. Research summaries compare its receptor affinity favorably against mitragynine and 7OH.

That suggests Pseudo may be extremely potent.

But real-world product strength depends on the actual formulation. A tablet marketed as Pseudo may contain different amounts of active compound from another tablet with the same label.

So the better answer is this:

Pseudo has the potential to be stronger than 7OH, but the strength of any tablet depends on its formulation, purity, and labeling accuracy.

This is exactly why lab testing matters.

Why are Pseudo Tablets Controversial?

Pseudo tablets are controversial because they sit at the edge of what many people consider “kratom.”

Traditional kratom advocates often argue that raw leaf powder and basic extracts should not be grouped with heavily concentrated alkaloid products. They worry that products like Pseudo tablets, 7OH tablets, and other enhanced formulas could bring more regulatory attention to the entire kratom industry.

That concern has become more serious since 2025.

U.S. health officials have pushed for tighter restrictions on concentrated 7OH products. AP reported that the FDA issued warning letters to companies marketing 7OH products and recommended that DEA place 7OH into Schedule I. The agency stated that the action was not focused on natural kratom leaf products.

That distinction is important.

Regulators appear to be separating traditional kratom leaf from highly concentrated alkaloid products. Pseudo tablets may fall into that same area of concern because they are not simple plant powder.

The more products resemble powerful opioid-style tablets, the more scrutiny they are likely to receive.

Safety Concerns With Pseudo Tablets

The biggest safety issue is not just strength. It is uncertain.

Pseudo tablets are sold in a market that does not have the same controls as prescription medications. There may be no consistent standard for purity, dosage, testing, or labeling.

That can make consumer risk hard to predict.

Possible concerns include:

• Nausea and vomiting.
• Dizziness or heavy sedation.
• Constipation.
• Tolerance buildup.
• Dependence and withdrawal.
• Impaired coordination.
• Risk when combined with alcohol or sedatives.

Kratom products have been associated with dependence and withdrawal in some users, especially with frequent or high-dose use. The FDA and other health officials have also raised concerns about addiction, injuries, and deaths tied to kratom-related products.

Pseudo tablets may increase these concerns because they are more concentrated than traditional kratom leaf.

They should never be mixed with alcohol, benzodiazepines, opioids, sleep medications, or other depressants. Combining sedating substances can increase the risk of dangerous breathing problems.

Are Pseudo Tablets Legal?

The legal status is complicated.

Kratom itself is not federally scheduled in the United States, but it is illegal in several states and restricted in some local areas. As of 2026, reports list multiple states with kratom bans or active restrictions, and some local governments have also taken action.

Pseudo tablets may face more legal uncertainty than regular kratom because they involve concentrated or transformed alkaloids.

That means legality may depend on several factors. These include the state, the exact compound, how it is made, how it is marketed, and whether future federal action targets related kratom derivatives.

The FDA’s 2025 push against concentrated 7OH products shows where regulators may be heading. While that action was not described as targeting natural kratom leaf, it did focus on high-potency alkaloid products sold in forms like tablets, gummies, and drinks.

For consumers, the safest assumption is this:

Do not assume Pseudo tablets are legal just because regular kratom is legal in your state.

Check current laws before buying or carrying these products.

How to Think About Pseudo Tablets?

The simplest way to understand Pseudo tablets is to place them on a spectrum.

At one end, you have a traditional kratom leaf. It is closer to historical use and contains a natural alkaloid profile.

In the middle, you have MIT extracts and basic kratom shots. These are stronger than leaf but still centered around mitragynine.

Further along, you have 7OH products. These are more concentrated and more controversial.

Pseudo tablets sit near the far end of that spectrum. They are built around a potent kratom-related compound that may act very differently from ordinary kratom powder.

That does not automatically mean every product is unsafe. But it does mean consumers should approach them with more caution.

A product can be kratom-derived and still be very different from kratom leaf.

That is the key takeaway.

Who Should Avoid Pseudo Tablets?

Pseudo tablets are not ideal for beginners.

They may also be a poor fit for anyone with a history of opioid dependence, sensitivity to sedatives, respiratory problems, or regular use of alcohol, benzodiazepines, sleep medications, or prescription opioids.

People who need to drive, operate equipment, or work in safety-sensitive environments should also be cautious. Strong sedation or impaired coordination can be dangerous.

These products are usually marketed to experienced users for a reason. Even then, experience does not remove risk.

Frequently Asked Questions

Q. What are Pseudo tablets?

Pseudo tablets are concentrated kratom alkaloid products usually associated with mitragynine pseudoindoxyl. They are different from regular kratom powder because they focus on a much more potent kratom-related compound.

Q. Is Pseudo the same as kratom?

No. Pseudo is kratom-related, but Pseudo tablets are not the same as traditional kratom leaf. They are more concentrated and may produce stronger effects.

Q. Is mitragynine pseudoindoxyl natural?

It is connected to kratom alkaloid chemistry and can form as a metabolite of 7OH. Commercial products may involve concentration or chemical transformation, so they should not be treated the same as raw kratom leaf.

Q. Are Pseudo tablets stronger than 7OH?

They may be. Mitragynine pseudoindoxyl has been described as having very strong opioid receptor affinity, but commercial product strength depends on formulation and labeling accuracy.

Q. Are Pseudo tablets legal?

Their legal status is uncertain and may vary by location. Kratom legality already differs by state, and concentrated alkaloid products may face greater scrutiny.

Q. Are Pseudo tablets FDA-approved?

No. Pseudo tablets are not FDA-approved medications or approved dietary supplement ingredients.

Q. Can Pseudo tablets cause withdrawal?

There is concern that potent kratom-related products may cause dependence or withdrawal with repeated use. The risk may be higher with concentrated products than with traditional leaf.

Q. Why are Pseudo tablets controversial?

They are controversial because they blur the line between traditional kratom and high-potency opioid-like alkaloid products. This may increase safety concerns and regulatory pressure.

Final Thoughts

Pseudo tablets are one of the most important new categories in the modern kratom market.

They are not just another form of regular kratom. They are concentrated alkaloid products associated with mitragynine pseudoindoxyl, a compound connected to 7OH and opioid receptor activity.

That makes them powerful, but also uncertain.

For some experienced consumers, Pseudo tablets may seem appealing because they are compact, strong, and fast-moving. But those same qualities also create real concerns around tolerance, dependence, labeling accuracy, legal risk, and long-term safety.

The biggest mistake is assuming that “kratom-derived” means “the same as kratom leaf.”

It does not.

Pseudo tablets sit in a different category. They are closer to modern concentrated alkaloid products than traditional botanical kratom. As regulators continue focusing on high-potency kratom derivatives, these tablets will likely remain under close attention.

For readers, the best approach is simple: stay informed, be cautious, and understand that potency always comes with tradeoffs.